Gerald M. Lieberman - 01 Apr 2025 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Apr 2025, 16:06:27 UTC
Prior SEC filing
17 Jan 2025
Next SEC filing
09 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dana Yaacov-Garbeli, Attorney-in-Fact

Key filing fact

Gerald M. Lieberman filed Form 4 for Entera Bio Ltd. (ENTX) on 03 Apr 2025.

Key facts

  • This page summarizes Gerald M. Lieberman's Form 4 filing for Entera Bio Ltd. (ENTX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Apr 2025, 16:06.

Change

  • Previous filing in this sequence was filed on 17 Jan 2025.
  • Current net transaction value: +$23,952.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENTX transaction

Ordinary Shares, par value NIS 0.0000769 per share

Options Exercise

Transaction value
$23,952
Shares
+23,952
Change %
+8.7%
Price
$1.00
Shares after
300,160
Date
01 Apr 2025
Ownership
Direct
ENTX holding

Ordinary Shares, par value NIS 0.0000769 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,200
Date
01 Apr 2025
Ownership
By Trust
Footnotes
F1
ENTX holding

Ordinary Shares, par value NIS 0.0000769 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,200
Date
01 Apr 2025
Ownership
By Trust
Footnotes
F1
ENTX holding

Ordinary Shares, par value NIS 0.0000769 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,200
Date
01 Apr 2025
Ownership
By Trust
Footnotes
F1
ENTX holding

Ordinary Shares, par value NIS 0.0000769 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,200
Date
01 Apr 2025
Ownership
By Trust
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENTX transaction Derivative

Warrant (right to buy)

Options Exercise

Transaction value
$0
Shares
-23,952
Change %
-46%
Price
$0.000000
Shares after
28,509
Date
01 Apr 2025
Ownership
Direct
Underlying class
Ordinary Shares, par value NIS 0.0000769 per share
Underlying amount
23,952
Exercise price
$1.00
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .